A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a ...
Morning Overview on MSN
A prostate cancer drug halved the odds of the disease spreading
Men diagnosed with high-risk localized prostate cancer now have trial-level evidence that adding the drug apalutamide to ...
The partnership will evaluate whether imaging- and biomarker-informed insights can support a more personalised approach to ...
PET scan changed treatment plans for nearly half of patients whose first scan was negative, according to new research ...
Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the ...
4don MSN
Nebraska Hematology Oncology becomes state’s only trial site for new prostate cancer treatment
The treatment, called Pasritamig, teaches the immune system's T cells to target and attack cancer cells in the prostate.
Thousands of men with prostate cancer will be offered a more targeted radiotherapy by the NHS which requires just five doses.
Prostate cancer relapse treatment could be cut from 35 visits to just five. See how new radiation technology may change your ...
A pioneering new therapy will 'transform' treatment, according to health chiefs.
Prostate cancer is the most common cancer in men in the UK, with more than 55,000 men being diagnosed every year ...
The Gazette offers audio versions of articles using Instaread. Some words may be mispronounced. Herb Hoover is getting to the point in his life where he is very interested in longevity. Hoover was ...
NeoGenomics, Inc.(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of PTEN IHC CDx, the first immunohistochemistry (IHC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results